PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22571867-10	2013	Of four patients with paired data, three (including a responder to pranlukast) showed decreased pro-inflammatory cytokines (IL-1beta, IL-6, and TNFalpha), and four showed decreased sTNFR1, after pranlukast treatment, and only a responder had markedly decreased frequency of CD8+ T cells in CSF.	pranlukast	67-77	interleukin 6	Homo sapiens	134-138	
12801316-11	2003	CONCLUSION: Pranlukast and MK-571 partially inhibited NF-kappa B activation in 1.3% DMSO-differentiated U-937 and Jurkat cells, and IL-6 release in PBMC.	pranlukast	12-22	interleukin 6	Homo sapiens	132-136	
12801316-10	2003	Moreover, 10-5 M pranlukast and MK-571 inhibited LPS-induced IL-6 production in PBMC by about 65% and 15%, respectively.	pranlukast	17-27	interleukin 6	Homo sapiens	61-65